- E-postIvan.Rios-Mondragon@uib.no
- BesøksadresseÅrstadveien 195009 Bergen
- PostadressePostboks 78045020 Bergen
Vitenskapelig artikkel
- (2022). Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models. Biomedicine and Pharmacotherapy. 14 sider.
- (2017). Phosphorylation at serine 31 targets tyrosine hydroxylase to vesicles for transport along microtubules. Journal of Biological Chemistry. 14092-14107.
- (2015). Novel microscopy-based screening method reveals regulators of contact-dependent intercellular transfer. Scientific Reports.
- (2015). Intercellular transfer of transferrin receptor by a contact-, Rab8-dependent mechanism involving tunneling nanotubes. The FASEB Journal. 4695-4712.
- (2012). Spatio-temporal analysis of tamoxifen-induced bystander effects in breast cancer cells using microfluidics. Biomicrofluidics. 9 sider.
Vitenskapelig foredrag
- (2019). Microfluidic-based Biomimetic Models for Therapeutic and Hazard Risk Assessment of Manufactured Nanomaterials.
- (2017). Presentasjon av Nano-prosjekter.
Mastergradsoppgave
- (2018). Impedance-based microfluidic device for assessing the cytotoxicity of nanoparticles.
Doktorgradsavhandling
- (2012). Near-field studies on intercellular communication.
Poster
- (2019). Nanocarrier-directed drug delivery for breast cancer treatment.
- (2019). Label-free impedance-based nanotoxicity testing: Static vs. dynamic exposure to nanomaterials.
- (2019). Biomimetic impedance-based assessment of the biological effects of anticancer nanoparticles .
- (2018). Label-free impedimetric analysis of the cytotoxic effects of nanomaterials under dynamic in-vivo like conditions.
Vitenskapelig oversiktsartikkel/review
- (2020). Epigenetics in breast cancer therapy—New strategies and future nanomedicine perspectives. Cancers. 32 sider.
- (2019). Microfluidics for studying metastatic patterns of lung cancer. Journal of Nanobiotechnology. 1-30.